NZYM B Novozymes A/S Class B

Major shareholder announcement

Major shareholder announcement

Please read the full announcement in PDF

Attachments



EN
07/11/2025

Underlying

NZYM BNovozymes A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Major shareholder announcement

Major shareholder announcement Please read the full announcement in PDF Attachments

4h / 4m 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Novonesis delivered 8% organic sales growth in the first nine months o...

Novonesis delivered 8% organic sales growth in the first nine months of 2025 Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards.  COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, previously 6-8%. Ester Baiget, President & CEO:  "I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability. Our performance was strong across all sales areas and i...

November 6, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

8% organic sales growth after first nine months. Full-year organic sal...

8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards. Ester Baiget, President & CEO: ”I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all sales areas and in Emerging and Developed Markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds, demonstrating the strength and resilience of our business model. Following a robust nine-months performance including favorable timing in the third quar...

November 6, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen matching shares program and the legacy Chr. Hansen 2023 restricted stock units (RSU) program.  Attachment ...

November 4, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Noma and Novonesis partner to scale deliciousness

Noma and Novonesis partner to scale deliciousness Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the next level. Together, they’re fusing culinary craft with biology to create flavors and products that are healthier, tastier, and better for the planet. COPENHAGEN, 23 October 2025: Innovation pushes boundaries and, at times, returns to the beginning. For thousands of years, we have used biology to craft our rich tapestry of food and beverage tr...

October 23, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch